Choomâ„¢ Completes Acquisition of Clarity Cannabis Medical Centre
Choomâ„¢ Completes Acquisition of Clarity Cannabis Medical Centre |
[10-December-2018] |
VANCOUVER, Dec. 10, 2018 /CNW/ - Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company" or "Choom") an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that effective December 10, 2018 ChoomTM has closed its previously announced acquisition of all of the issued and outstanding securities of Clarity Cannabis Medical Centre Inc., 1165962 B.C. Ltd., Western Cannabis Coaching Centre Ltd. and Universal Cannabis Coaching Inc., together doing business as "Clarity Cannabis Medical Centre". In consideration for all of the issued and outstanding securities of Clarity Cannabis Medical Centre (the "Transaction"), ChoomTM issued an aggregate of 1,915,973 common shares in the capital of ChoomTM (the "Choom Shares"), and an aggregate of $100,002 in cash to the shareholders of Clarity Cannabis Medical Centre. A portion of the Choom Shares issued to certain shareholders of Clarity Cannabis Medical Centre are subject to an escrow. Strategic Reduction of Interest in Specialty Medijuana Products Inc. In connection with Choom's strategic plan to focus on developing a network of retail stores which will feature a curated selection of products from various licensed producers, Choom has completed a transaction (the "SMP Transaction"), whereby Choom, through its wholly-owned direct subsidiary, Arbutus Brands Inc. ("Arbutus"), divested 90.2% of its interest in Specialty Medijuana Products Inc., a wholly-owned direct subsidiary of Arbutus ("SMP"), resulting in Choom indirectly holding a 9.8% interest in SMP. In exchange for the transfer of partial ownership of SMP, the recipients of the 90.2% interest in SMP have surrendered and cancelled share commitments of Choom pursuant to which the holders thereof could have purchased an aggregate of 37,970,445 common shares in the capital of Choom. Chris Bogart, President & CEO states, "as part of our strategic business plan to be a leading national cannabis retailer Choom has taken the necessary steps to assure our license applications comply with each provincial governing body across Canada. Choom has no plans to be a licensed producer and will focus exclusively on its adult use retail and medical centres, as well as, brands portfolio." In connection with the SMP Transaction, a director of Choom indirectly received shares in SMP, representing an ownership percentage of 26.48% of SMP. The participation of the director in the transaction constitutes a "related party transaction" within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transaction ("MI 61-101"). The SMP Transaction is exempt from the formal valuation requirements of MI 61-101 pursuant to section 5.5(a) and the minority approval requirements of MI 61-101 pursuant to section 5.7(1)(a) on the basis that the fair market value of the director's participation is not more than 25% of the Company's market capitalization. The Company did not file a material change report more than 21 days in advance of closing of the SMP Transaction as contemplated by the related party transaction requirements under MI 61-101 as the completion of the SMP Transaction was concurrent with the signing of the SMP Transaction share purchase agreement. SAY HELLO TO CHOOMTM "Chris Bogart" Cautionary Statement: NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Forward-looking information SOURCE Choom Holdings Inc. | ||
Company Codes: OTC-QB:CHOOF, CNSX:CHOO |
© 2018 PR Newswire. All Rights Reserved.